REDW — Redwood Pharma AB Cashflow Statement
0.000.00%
- SEK25.16m
- SEK24.34m
Annual cashflow statement for Redwood Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -15.5 | -14.5 | -20.5 | -13 | -13.5 |
Non-Cash Items | — | — | — | — | 0.545 |
Other Non-Cash Items | |||||
Changes in Working Capital | -2.02 | 3.51 | -0.986 | -2.66 | -2.53 |
Change in Accounts Receivable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -17.5 | -11 | -21.5 | -15.7 | -15.5 |
Capital Expenditures | 0 | — | — | -0.282 | -3.94 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | 0 | -0.002 | 0 | — |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | 0 | 0 | -0.002 | -0.282 | -3.94 |
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 15 | 9.45 | 29.7 | 12.4 | 12.5 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -2.53 | -1.56 | 8.19 | -3.54 | -6.97 |